Phase II study of oxaliplatin in patients with relapsed or refractory non-Hodgkin's lymphoma: Final results.

被引：0
|
作者：
Oki, Y [1 ]
McLauhlin, P [1 ]
Pro, B [1 ]
Hagemeister, FH [1 ]
Bleyer, A [1 ]
Loyer, E [1 ]
Younes, A [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2494
引用
收藏
页码：684A / 684A
页数：1
相关论文
共 50 条
  • [1] Phase II study of oxaliplatin in patients with recurrent or refractory non-Hodgkin lymphoma
    Oki, Y
    McLaughlin, P
    Pro, B
    Hagemeister, FB
    Bleyer, A
    Loyer, E
    Younes, A
    [J]. CANCER, 2005, 104 (04) : 781 - 787
  • [2] Phase II study of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymhoma (NHL)
    Younes, A
    McLaughlin, P
    Pro, B
    Hagemeister, F
    Bleyer, A
    [J]. BLOOD, 2003, 102 (11) : 639A - 640A
  • [3] Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin’s lymphoma
    Seon-Kyeong Kim
    Moo-Kon Song
    Joo Seop Chung
    Ho-Jin Shin
    [J]. International Journal of Hematology, 2013, 98 : 543 - 548
  • [4] Phase II study of ifosfamide, etoposide, and oxaliplatin (IFETOx) chemotherapy for relapsed or refractory non-Hodgkin's lymphoma
    Kim, Seon-Kyeong
    Song, Moo-Kon
    Chung, Joo Seop
    Shin, Ho-Jin
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (05) : 543 - 548
  • [5] Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
    Ribrag, Vincent
    Caballero, Dolores
    Ferme, Christophe
    Zucca, Emanuele
    Arranz, Reyes
    Briones, Javier
    Gisselbrecht, Christian
    Salles, Gilles
    Gianni, Alessandro M.
    Gomez, Henry
    Kahatt, Carmen
    Corrado, Claudia
    Szyldergemajn, Sergio
    Extremera, Sonia
    de Miguel, Bernardo
    Cullell-Young, Martin
    Cavalli, Franco
    [J]. HAEMATOLOGICA, 2013, 98 (03) : 357 - 363
  • [6] Dexamethasone, cytarabine and oxaliplatin (DHAX) in relapsed or refractory non-Hodgkin's lymphoma patients: Results of an ongoing phase II trial.
    Chau, I
    Cunningham, D
    Hill, M
    Catovsky, D
    [J]. BLOOD, 2000, 96 (11) : 140A - 140A
  • [7] A phase II trial of gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for patients with refractory or relapsed non-Hodgkin's lymphoma
    Park, B.
    Kim, W.
    Eom, H.
    Kim, J.
    Oh, S.
    Suh, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma
    Hosein, Peter J.
    Craig, Michael D.
    Tallman, Martin S.
    Boccia, Ralph V.
    Hamilton, Brian L.
    Lewis, Jonathan J.
    Lossos, Izidore S.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (01) : 111 - 114
  • [9] A PHASE II TRIAL OF GEMCITABINE, IFOSFAMIDE, DEXAMATHASONE, AND OXALIPLATIN (GIDOX) FOR PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN'S LYMPHOMA
    Park, B. B.
    Kim, W. S.
    Eom, H. S.
    Kim, J. S.
    Oh, S. J.
    Hwang, I. G.
    Suh, C.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 652 - 652
  • [10] Activity of oxaliplatin in patients with relapsed and refractory non-Hodgkin lymphoma.
    Younes, A
    McLaughlin, P
    Pro, B
    Hagemeister, FB
    Fayad, L
    Romaguera, J
    [J]. BLOOD, 2002, 100 (11) : 296B - 296B
12345